Delivery Order SPE2DB22D1017-SPE2DB25FG3XK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Dupixent 300 mg/2 ml pens with a ceiling value of $4,735.80. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of April 24, 2025. The contract represents a pharmaceutical supply delivery under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $8,322.75. This firm fixed price delivery order, which is set to be completed by August 28, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,893.05 on June 17, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance will be completed by June 18, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dupixent 300 mg/2 mL pens, with a contract ceiling value of $52,595.52 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $5,128.38. This firm fixed-price, non-set-aside contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999 and extends through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $10,809.15 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on July 30, 2025, with completion scheduled for July 31, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a firm fixed price ceiling value of $8,586.48. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $38,528.12 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dupixent 200 mg/1.14 mL pen injections, with a ceiling value of $20,906.28 under a firm fixed-price contract. This non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply framework with DLA and is scheduled for completion by August 12, 2025. The pharmaceutical will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $21,408.43 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract employs firm fixed price terms with no set-aside designation, indicating competitive award status. Performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG3XKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $14,717.10. This competitively awarded, firm fixed-price contract is scheduled for completion by June 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies across the Defense Logistics Agency's medical supply chain. As a prime contractor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, the company demonstrates consistent capability in meeting federal procurement requirements through open competition. This Dupixent delivery order supports the military healthcare system's pharmaceutical supply needs for immunological and inflammatory condition treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 5/30/25 |